ANVS - Annovis Bio GAAP EPS of -$6.23 misses by $3.15
2024-04-02 07:37:07 ET
More on Annovis Bio
- Annovis: Potentially Encouraging Anecdotes, Weighing Phase 3 Parkinson's Prospects
- Annovis And Alzheimer's Disease: The Best-Laid Plans
- Stocks To Watch: Eyes On Chipmakers, Tesla, Netflix And BrightSpring IPO
- Annovis to release efficacy data on Alzheimer's drug in April
- Annovis Bio falls after Brookline Capital downgrades on PD trial complications